Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P436: SPOSAB ABP 501 - A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501ECCO'21 Virtual
Year: 2021
Authors: Macaluso, F.(1);Cappello, M.(2);Busacca, A.(2);Fries, W.(3);Viola, A.(3);Costantino, G.(3);Magnano, A.(4);Vinci, E.(4);Ferracane, C.(4);Privitera, A.C.(5);Piccillo, G.(5);Belluardo, N.(6);Giangreco, E.(6);Romano, C.(7);Citrano, M.(8);Graziano, F.(8);Garufi, S.(9);Bertolami, C.(10);Scrivo, B.(1);Renna, S.(1);Casà, A.(1);Rizzuto, G.(1);Ventimiglia, M.(1);Orlando, A.(1);
(1)'Villa Sofia-Cervello' Hospital, IBD Unit- Department of Medicine, Palermo, Italy;(2)A.O.U. Policlinico “G. Giaccone”, Gastroenterology and Hepatology Unit, Palermo, Italy;(3)A.O.U. Policlinico 'G. Martino”, IBD Unit, Messina, Italy;(4)A.O.U. Policlinico “Vittorio Emanuele”, Gastroenterology Unit, Catania, Italy;(5)A.O. 'Cannizzaro”, IBD Unit, Catania, Italy;(6)A.O. “Guzzardi”, Gastroenterology Unit, Vittoria, Italy;(7)A.O.U. Policlinico “G. Martino”, Pediatric Gastroenterology Unit, Messina, Italy;(8)A.O.O.R. “Villa Sofia-Cervello”, Pediatric Unit, Palermo, Italy;(9)A.O.O.R. “S. Elia- M. Raimondi”, Gastroenterology Unit, Caltanissetta, Italy;(10)A.O.O.R. “Papardo Piemonte”, Gastroenterology Unit, Messina, Italy Sicilian Network for Inflammatory Bowel Disease (SN-IBD)
P437: Hyperbaric oxygen therapy for Inflammatory Bowel Disease – a systematic reviewECCO'21 Virtual
Year: 2021
Authors: Meima - van Praag, E.(1);Lansdorp, C.(2);Smeekes, G.(1);Gecse, K.(3);van Hulst, R.(2);Buskens, C.(1);
(1)Amsterdam UMC, Surgery, Amsterdam, The Netherlands;(2)Amsterdam UMC, Anaesthesiology and Hyperbaric Medicine, Amsterdam, The Netherlands;(3)Amsterdam UMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands
P438: Maladaptive decision-making is associated with psychological morbidity in people with Inflammatory Bowel Disease.ECCO'21 Virtual
Year: 2021
Authors: Grinsted Tate, L.(1);Johnson, L.(1);Jones, G.(2);Lobo, A.(3);
(1)University of Sheffield, Medical School, Sheffield, United Kingdom;(2)School of Social Sciences- Leeds Beckett University, Department of Psychology, Leeds, United Kingdom;(3)University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, Academic Department of Gastroenterology, Sheffield, United Kingdom
P439: Effectiveness of Ustekinumab on Crohn's disease associated spondyloartropathy: real-world data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)ECCO'21 Virtual
Year: 2021
Authors: Macaluso, F.(1);Fries, W.(2);Viola, A.(2);Costantino, G.(2);Muscianisi, M.(2);Cappello, M.(3);Guida, L.(3);Giuffrida, E.(3);Magnano, A.(4);Pluchino, D.(4);Ferracane, C.(4);Magrì, G.(5);Di Mitri, R.(6);Mocciaro, F.(6);Privitera, A.C.(7);Camilleri, S.(8);Garufi, S.(8);Renna, S.(1);Casà, A.(1);Scrivo, B.(1);Ventimiglia, M.(1);Orlando, A.(1);
(1)'Villa Sofia-Cervello' Hospital, IBD Unit, Palermo, Italy;(2)A.O.U. Policlinico 'G. Martino”, IBD Unit, Messina, Italy;(3)A.O.U. Policlinico “G. Giaccone”, Gastroenterology and Hepatology Unit, Palermo, Italy;(4)A.O.U. Policlinico “Vittorio Emanuele”, Gastroenterology Unit, Catania, Italy;(5)A.O. “Santa Marta e S. Venera”, Gastroenterology Unit, Acireale, Italy;(6)A.R.N.A.S. “Civico Di Cristina Benfratelli”, Gastroenterology and Endoscopy Unit, Palermoo, Italy;(7)A.O. “Cannizzaro”, IBD Unit, Catania, Italy;(8)A.O.O.R. “S. Elia- M. Raimondi”, Gastroenterology Unit, Caltanissetta, Italy Sicilian Network for Inflammatory Bowel Disease (SN-IBD).
P440: First results of the BELCOMID study: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID)ECCO'21 Virtual
Year: 2021
Authors: Geldof, J.(1,2);Truyens, M.(1,2);Sabino, J.(3,4);Ferrante, M.(3,4);Lambert, J.(5);Lapeere, H.(5);Hillary, T.(6);Van Laethem, A.(6);De Vlam, K.(7);Verschueren, P.(7);Lobaton, T.(1,2);Vermeire, S.(3,4);
(1)University Hospital Ghent, Department of Gastroenterology and Hepatology, Ghent, Belgium;(2)Ghent University, Department of Internal Medicine and Pediatrics, Ghent, Belgium;(3)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(4)Translational Research Center for Gastrointestinal Disorders TARGID- KU Leuven, Department of Chronic Diseases- Metabolism- and Ageing CHROMETA, Leuven, Belgium;(5)University Hospital Ghent, Department of Dermatology, Ghent, Belgium;(6)University Hospitals Leuven, Department of Dermatology, Leuven, Belgium;(7)University Hospitals Leuven, Department of Rheumatology, Leuven, Belgium BELCOMID
P441: Clinical efficacy, drug sustainability and results from therapeutic drug monitoring in Crohn’s disease patients treated with ustekinumab – 1-year follow-up of a prospective, nationwide, multicenter cohort from HungaryECCO'21 Virtual
Year: 2021
Authors: Gonczi, L.(1);Szanto, K.(2);Farkas, K.(2);Molnar, T.(2);Szamosi, T.(3);Schafer , E.(3);Golovics, P.(3);Lovasz, B.(1);Patai, A.(4);Vincze, A.(5);Sarlos, P.(5);Farkas, A.(6);Dubrovcsik, Z.(6);Tóth G., T.(7);Lakatos, P.L.(8);Miheller, P.(9);Ilias, A.(1);
(1)Semmelweis University, 1st Department of Medicine, Budapest, Hungary;(2)University of Szeged, 1st Department of Internal Medicine, Szeged, Hungary;(3)Military Hospital—State Health Centre, Department of Gastroenterology, Budapest, Hungary;(4)Markusovszky Hospital, Department of Medicine and Gastroenterology, Szombathely, Hungary;(5)University of Pecs, First Department of Medicine, Pecs, Hungary;(6)Bács-Kiskun County Hospital, Department of Gastroenterology, Kecskemét, Hungary;(7)St. Janos Hospital, Department of Gastroenterology, Budapest, Hungary;(8)McGill University Health Centre, Division of Gastroenterology, Montreal, Canada;(9)Semmelweis University, 1st Department of Surgery, Budapest, Hungary
P442: Serum vedolizumab trough levels are associated with remission rate but not with extra-intestinal manifestations in IBD patientsECCO'21 Virtual
Year: 2021
Authors: Tzadok, R.(1);Fliss-Isakov, N.(2);Aviv Cohen, N.(2);Ron, Y.(2);Maharshak, N.(2);Hirsch, A.(2);
(1)Tel Aviv Sourasky Medical Center and Sackler School of Medicine- Tel Aviv University- Tel Aviv- Israel, Department of Internal Medicine H- Tel Aviv Sourasky Medical Center and Sackler School of Medicine- Tel Aviv University- Tel Aviv- Israel, Tel Aviv, Israel;(2)Tel Aviv Sourasky Medical Center and Sackler School of Medicine- Tel Aviv University- Tel Aviv- Israel, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel
P443: Haemorrhoidal Artery Ligation – Recto-Anal Repair (HAL-RAR) with mucopexy for grade III hemorrhoids in IBD patientsECCO'21 Virtual
Year: 2021
Authors: Laureti, S.(1);Cardelli, S.(1);Gionchetti, P.(1);Rizzello, F.(1);Calabrese, C.(1);Poggioli, G.(1);
(1)University of Bologna - IRCCS Azienda Ospedaliera-Universitaria S. Orsola Malpighi Bologna, Department of Medicine and Surgery DIMEC, Bologna, Italy
P444: Fecal calprotectin response to anti-tumor necrosis factor alpha induction and maintenance in Pediatric Inflammatory Bowel DiseaseECCO'21 Virtual
Year: 2021
Authors: Matar, M.(1);Levi, R.(2);Zvuloni, M.(3);Shamir, R.(1,3);Assa, A.(1,4);
(1)Schneider Children's Hospital, The institute of Gastroenterology- Nutrition and Liver diseases, Petach-Tikva, Israel;(2)Schneider Children's Hospital, Pediatric department A, Petach-Tikva, Israel;(3)The Sackler Faculty of Medicine- Tel Aviv University, Medicin department, Tel Aviv, Israel;(4)The Ben-Gurion University of the Negev- Beer Sheva, Medicin department, Beer Sheva, Israel
P445: Does The Sequence Matter ? Comparative effectiveness of a second line biologic in patients with Ulcerative Colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumabECCO'21 Virtual
Year: 2021
Authors: Miller, C.(1);Kwok, H.(1);Parisi, I.(1);Harrow, P.(1);McCartney, S.(1);Vega, R.(1);Rahman, F.(1);Seward, E.(1);Mehta, S.(1);Lim, S.(2);Sharma, E.(2);Samaan, M.(2);Bancil, A.(3);Kok, K.(3);Shalabi, A.(4);Johnston, E.(4);Katarey, D.(5);Taherzadeh, N.(5);Murray, C.(5);Sharip, M.(6);Carter, M.(6);Radhakrishnan, S.(7);Peake, S.(7);Khakoo, I.(8);Wahed, M.(8);Povlsen, S.(9);Patel, M.(9);Dubois, P.(9);Finkel, J.(10);Onnie, C.(10);Bloom, S.(1);
(1)University College Hospital, Gastroenterology Department, London, United Kingdom;(2)Guy's and Thomas' Hospital, Gastroenterology Department, London, United Kingdom;(3)Royal London Hospital, Gastroenterology Department, London, United Kingdom;(4)West Middlesex Hospital, Gastroenterology Department, London, United Kingdom;(5)Royal Free Hospital, Gastroenterology Department, London, United Kingdom;(6)Lister Hospital, Gastroenterology Department, Stevenage, United Kingdom;(7)St Mary's Hospital, Gastroenterology Department, London, United Kingdom;(8)Chelsea and Westminster Hospital, Gastroenterology Department, London, United Kingdom;(9)King's College Hospital, Gastroenterology Department, London, United Kingdom;(10)Whittington Hospital, Gastroenterology Department, London, United Kingdom
P446: Plasma rich in growing factors as treatment for perianal fistulas in Crohn’s disease: unicentre experience.ECCO'21 Virtual
Year: 2021
Authors: Soto Sánchez, A.(1);Hernandez Camba, A.(2);Hernández, M.(1);Hernández, G.(1);Pérez Sánchez, E.(1);Barrera Gómez, M.(1);
(1)Hosp. Universitario Nuestra Señora de la Candelaria, Department of Surgery, Santa Cruz de Tenerife, Spain;(2)Hosp. Universitario Nuestra Señora de la Candelaria, Department of Gastroenterology, Santa Cruz de Tenerife, Spain
P447: Combined fibrin glue with infliximab therapy of postoperative anastomotic fistula in patients with Crohn`s disease:A Pilot studyECCO'21 Virtual
Year: 2021
Authors: Li, Y.(1);Yao, D.(1);
(1)Shanghai Ninth People's Hospital -Shanghai Jiaotong University School, Department of Surgery, Shanghai, China
P448: Safety of anti-TNF introduction following tuberculosis treatment in Inflammatory Bowel Disease patients in an endemic areaECCO'21 Virtual
Year: 2021
Authors: Azevedo, M.F.C.D.(1);Justus, F.F.(1);Lima, C.C.G.(1);Garcia, K.S.(1);Barros, L.L.(1);Oba, J.(1);Carlos, A.D.S.(1);Milani, L.R.(1);Sipahi, A.M.(1);Damião, A.O.M.C.(1);Queiroz, N.S.F.(1);
(1)University of São Paulo School of Medicine, Gastroenterology, São Paulo, Brazil
P449: Cost Effectiveness of a Proactive Therapeutic Drug Monitoring Strategy in Patients with Inflammatory Bowel Disease Receiving InfliximabECCO'21 Virtual
Year: 2021
Authors: Doherty, J.(1);Varley, R.(1);Healy, M.(2);Dunne, C.(1);Mac Carthy, F.(1);Mc Kiernan, S.(1);Hartery, K.(1);Kevans, D.(1);
(1)St James Hospital, Department of Gastroenterology, Dublin 8, Ireland;(2)St James Hospital, Department of Biochemistry, Dublin 8, Ireland
P450: Vaccination strategies in Inflammatory Bowel Disease patients: perspective of physicians and patients.ECCO'21 Virtual
Year: 2021
Authors: Ferreiro Iglesias, R.(1);Hernández Camba, A.(2);Saldaña, R.(3);Rodríguez-Lago, I.(4);Zabana, Y.(5);Barreiro-de Acosta, M.(6);
(1)Hospital Clinico Universitario de Santiago. Fundación Instituto de Investigación Sanitaria de Santiago de Compostela IDIS, Gastroenterology Department, Santiago de Compostela, Spain;(2)Hospital Universitario Nuestra Señora de Candelaria., Gastroenterology Department., Tenerife, Spain;(3)ACCU-Spain, Managing Director, Madrid, Spain;(4)Hospital Universitario de Galdakao, Gastroenterology Department, Bilbao, Spain;(5)Hospital Universitari Mútua de Terrassa. Centro Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Department, Barcelona, Spain;(6)Hospital Clínico Universitario de Santiago. Fundación Instituto de Investigación Sanitaria de Santiago de Compostela IDIS, Gastroenterology Department, Santiago de Compostela, Spain; On behalf of Young Group of GETECCU and ACCU
P451: Efficacy and safety of tofacitinib in the treatment of patients with active, moderate to severe, Ulcerative Colitis: a systematic review and meta-analysisECCO'21 Virtual
Year: 2021
Authors: KhorshidFASGE, M.(1);Dorgham, D.(2);Sharobim, A.(3);Attia, M.(4);Hussein, M.(5);Dorgham, N.(6);
(1)EDGE Foundation, Department of Clinical Research, Cairo, Egypt;(2)Cairo University, Department of Rheumatology, Cairo, Egypt;(3)National Research Center, Department of Dermatology, Cairo, Egypt;(4)Cairo University, Department of Internal Medicine, Cairo, Egypt;(5)Al-Azhar University, Department of Internal Medicine, Cairo, Egypt;(6)Cairo University, Department of Dermatology, Cairo, Egypt
P452: Oral ciclosporin is a convenient, effective and safe rescue therapy in steroid refractory Acute Severe Ulcerative Colitis: A single tertiary centre experienceECCO'21 Virtual
Year: 2021
Authors: Jiang, C.D.(1);Thalagala, T.(1);Rosembert, D.(2);Parkes, M.(1);Lee, J.(1);Raine, T.(1);
(1)Addenbrooke’s Hospital- Cambridge University Hospitals NHS Foundation Trust, Gastroenterology, Cambridge, United Kingdom;(2)Addenbrooke’s Hospital- Cambridge University Hospitals NHS Foundation Trust, Clinical Pharmacy, Cambridge, United Kingdom
P453: The use of immunosuppresants is associated with high treatment persistence rates for infliximab and adalimumab as first or second line anti-TNF therapy in patients with inflammatory bowel diseaseECCO'21 Virtual
Year: 2021
Authors: Theodoraki, E.(1);Orfanoudaki, E.(1);Foteinogiannopoulou, K.(1);Drygiannakis, I.(1);Koutroubakis, I.E.(1);
(1)University Hospital of Heraklion, Department of Gastroenterology, Heraklion, Greece
P454: Treatment with biologics improves disability from Inflammatory Bowel Disease in therapy respondersECCO'21 Virtual
Year: 2021
Authors: Castillo, G.(1);Sultan, K.(2);Kwah, J.(3);Chen, L.A.(4);Axelrad, J.(3);
(1)New York University School Of Medicine, Internal Medicine, New York, United States;(2)Northwell Health, Gastroenterology, New York, United States;(3)New York University School of Medicine, Gastroenterology, New York, United States;(4)Rutgers School of Medicine, Gastroenterology, Newark, United States
P455: Tofacitinib Therapy is Effective for Arthralgias Associated with Active Inflammatory Bowel DiseaseECCO'21 Virtual
Year: 2021
Authors: Silfen, A.(1);Cohen, N.(1);Traboulsi, C.(1);Rodriguez, T.(1);Steinberg, J.(1);Singer, J.(1);Patel, S.(1);Cohen, R.(1);Dalal, S.(1);Micic, D.(1);Pekow, J.(1);Sakuraba, A.(1);Rubin, D.(1);
(1)University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States